{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:00:15Z","timestamp":1790402415144,"version":"4.1.0"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0239233","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T13:30:41Z","timestamp":1600090241000},"page":"e0239233","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["The influence of topical non-steroidal anti-inflammatory drugs on the intraocular pressure lowering effect of topical prostaglandin analogues\u2014A systemic review and meta-analysis"],"prefix":"10.1371","volume":"15","author":[{"given":"Kang-Jung","family":"Lo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chieh","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6346-8485","authenticated-orcid":true,"given":"De-Kuang","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine Jui-Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,9,14]]},"reference":[{"issue":"18","key":"pone.0239233.ref001","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"R.N. Weinreb","year":"2014","journal-title":"Jama"},{"issue":"2","key":"pone.0239233.ref002","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00061198-200004000-00002","article-title":"Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma","volume":"9","author":"S. Asrani","year":"2000","journal-title":"J Glaucoma"},{"issue":"3","key":"pone.0239233.ref003","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1185\/030079907X178720","article-title":"A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy","volume":"23","author":"P. Denis","year":"2007","journal-title":"Curr Med Res Opin"},{"issue":"11","key":"pone.0239233.ref004","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/ccr3.701","article-title":"Bone marrow sarcoidosis associated with long-term interferon-beta treatment for multiple sclerosis","volume":"4","author":"A. Teh","year":"2016","journal-title":"Clin Case Rep"},{"issue":"9","key":"pone.0239233.ref005","first-page":"2566","article-title":"Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension","volume":"41","author":"N. Orzalesi","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Suppl1","key":"pone.0239233.ref006","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/j.survophthal.2008.08.010","article-title":"Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction","volume":"53","author":"C.B. Toris","year":"2008","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"pone.0239233.ref007","doi-asserted-by":"crossref","first-page":"e0173254","DOI":"10.1371\/journal.pone.0173254","article-title":"Comparison of the efficacy and patients' tolerability of Nepafenac and Ketorolac in the treatment of ocular inflammation following cataract surgery: A meta-analysis of randomized controlled trials","volume":"12","author":"X. Zhao","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"pone.0239233.ref008","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12886-017-0405-7","article-title":"Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placebo","volume":"17","author":"S. McCafferty","year":"2017","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"pone.0239233.ref009","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00417-017-3599-8","article-title":"The comparative efficacy and safety of topical non-steroidal anti-inflammatory drugs for the treatment of anterior chamber inflammation after cataract surgery: a systematic review and network meta-analysis","volume":"255","author":"P. Duan","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"pone.0239233.ref010","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.2147\/OPTH.S86971","article-title":"Topical bromfenac for prevention and treatment of cystoid macular edema following cataract surgery: a review","volume":"10","author":"J.D. Sheppard","year":"2016","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"pone.0239233.ref011","doi-asserted-by":"crossref","first-page":"81s","DOI":"10.18433\/J3T886","article-title":"Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond","volume":"11","author":"P. Rao","year":"2008","journal-title":"J Pharm Pharm Sci"},{"issue":"5","key":"pone.0239233.ref012","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/02713680802100845","article-title":"Topical and oral ketorolac administration increases the intraocular pressure-lowering effect of latanoprost","volume":"33","author":"C. Costagliola","year":"2008","journal-title":"Curr Eye Res"},{"issue":"2","key":"pone.0239233.ref013","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ajo.2004.11.062","article-title":"Nimesulide oral administration increases the intraocular pressure-lowering effect of latanoprost in patients with primary open-angle glaucoma","volume":"141","author":"C. Costagliola","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"pone.0239233.ref014","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1136\/bjo.2005.080895","article-title":"Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost in patients with primary open angle glaucoma or ocular hypertension","volume":"90","author":"T. Chiba","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"pone.0239233.ref015","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1097\/IJG.0000000000000204","article-title":"The Interaction of Nepafenac and Prostaglandin Analogs in Primary Open-angle Glaucoma Patients","volume":"25","author":"P. Ozyol","year":"2016","journal-title":"J Glaucoma"},{"issue":"4","key":"pone.0239233.ref016","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/IJG.0b013e3181e07933","article-title":"The influence of topical diclofenac sodium on the ocular hypotensive effect of latanoprost in glaucoma patients","volume":"20","author":"R. Sorkhabi","year":"2011","journal-title":"J Glaucoma"},{"issue":"4","key":"pone.0239233.ref017","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000333822","article-title":"Effect of ketorolac add-on treatment on intra-ocular pressure in glaucoma patients receiving prostaglandin analogues","volume":"227","author":"E. Turan-Vural","year":"2012","journal-title":"Ophthalmologica"},{"key":"pone.0239233.ref018","article-title":"Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0","author":"P.T Julian","year":"2011","journal-title":"Cochrane Collaboration"},{"issue":"1","key":"pone.0239233.ref019","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0002-9394(01)01286-7","article-title":"Latanoprost and brimonidine: therapeutic and physiologic assessment before and after oral nonsteroidal anti-inflammatory therapy","volume":"133","author":"W.E. Sponsel","year":"2002","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"pone.0239233.ref020","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/jop.2015.0159","article-title":"Effect of Travoprost and Nonsteroidal Anti-Inflammatory Drug on Diurnal Intraocular Pressure in Normal Subjects with Low-Teen Baseline Intraocular Pressure","volume":"32","author":"R. Sakata","year":"2016","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"pone.0239233.ref021","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/bjo.87.3.297","article-title":"Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost","volume":"87","author":"K. Kashiwagi","year":"2003","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"pone.0239233.ref022","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.exer.2005.03.020","article-title":"The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients","volume":"81","author":"C. Costagliola","year":"2005","journal-title":"Exp Eye Res"},{"key":"pone.0239233.ref023","first-page":"7474086","article-title":"Effect of a Topical Combination of Latanoprost and Pranoprofen on Intraocular Pressure and the Ocular Surface in Open-Angle Glaucoma Patients","volume":"2018","author":"S. Zhu","year":"2018","journal-title":"Journal of Ophthalmology"},{"issue":"10","key":"pone.0239233.ref024","first-page":"1888","article-title":"Increases in retinovascular prostaglandin receptor functions by cyclooxygenase-1 and -2 inhibition","volume":"39","author":"P. Hardy","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"pone.0239233.ref025","first-page":"15","article-title":"Up-regulation of brain PGE2 and PGF2 alpha receptors and receptor-coupled second messengers by cyclooxygenase inhibition in newborn pigs","volume":"272","author":"D.Y. Li","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"pone.0239233.ref026","first-page":"2616","article-title":"Expression of cyclooxygenase-1 and -2 in normal and glaucomatous human eyes","volume":"42","author":"C. Maihofner","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"pone.0239233.ref027","first-page":"1127","article-title":"Alterations in arachidonic acid release and phospholipase C-beta(1) expression in glaucomatous human ciliary muscle cells","volume":"43","author":"S. Husain","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"pone.0239233.ref028","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10384-005-0293-x","article-title":"Latanoprost nonresponders with open-angle glaucoma in the Japanese population","volume":"50","author":"Y. Ikeda","year":"2006","journal-title":"Jpn J Ophthalmol"},{"issue":"12","key":"pone.0239233.ref029","first-page":"1845","article-title":"Differences in ocular biometrics and aqueous humour dynamics between Chinese and Caucasian adults","volume":"103","author":"S. Fan","year":"2019","journal-title":"British Journal of Ophthalmology"},{"issue":"2","key":"pone.0239233.ref030","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3102\/1076998609346961","article-title":"How Many Studies Do You Need?:A Primer on Statistical Power for Meta-Analysis","volume":"35","author":"J.C. Valentine","year":"2010","journal-title":"Journal of Educational and Behavioral Statistics"},{"issue":"1","key":"pone.0239233.ref031","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.rmed.2009.07.015","article-title":"A review of prostaglandin analogs in the management of patients with pulmonary arterial hypertension","volume":"104","author":"K.K. Mubarak","year":"2010","journal-title":"Respir Med"},{"issue":"Suppl 1","key":"pone.0239233.ref032","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1471-0528.2009.02329.x","article-title":"The use of misoprostol in obstetrics and gynaecology","volume":"116","author":"A. Elati","year":"2009","journal-title":"Bjog"},{"key":"pone.0239233.ref033","article-title":"Neurogenic Sexual Dysfunction Treatment: A Systematic Review","author":"G. Del Popolo","year":"2019","journal-title":"Eur Urol Focus"},{"issue":"5","key":"pone.0239233.ref034","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/ped.12769","article-title":"Prostaglandin E-mediated molecular mechanisms driving remodeling of the ductus arteriosus","volume":"57","author":"U. Yokoyama","year":"2015","journal-title":"Pediatr Int"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0239233","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T04:56:24Z","timestamp":1696654584000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0239233"}},"subtitle":[],"editor":[{"given":"Ted S.","family":"Acott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,9,14]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0239233","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.738661667.793578437","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,14]]}}}